First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIRE I Study
Background: The ALLEGRA (Biosensors International) transcatheter heart valve is a self-expanding supra-annular bovine pericardial aortic valve. A new delivery system (IMPERIA™, Biosensors International) has been designed which allows the valve to be fully resheathed and repositioned in situ. The aim...
Gardado en:
| Principais autores: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier
2025-04-01
|
| Series: | Structural Heart |
| Assuntos: | |
| Acceso en liña: | http://www.sciencedirect.com/science/article/pii/S2474870624001520 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
